Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Human BLyS facilitates engraftment of human PBL derived B cells in immunodeficient mice.

Schmidt MR, Appel MC, Giassi LJ, Greiner DL, Shultz LD, Woodland RT.

PLoS One. 2008 Sep 11;3(9):e3192. doi: 10.1371/journal.pone.0003192.

2.

Mechanism of BLyS action in B cell immunity.

Do RK, Chen-Kiang S.

Cytokine Growth Factor Rev. 2002 Feb;13(1):19-25. Review.

PMID:
11750877
3.
4.

Space, selection, and surveillance: setting boundaries with BLyS.

Miller JP, Stadanlick JE, Cancro MP.

J Immunol. 2006 Jun 1;176(11):6405-10. Review.

5.

B lymphocyte stimulator (BLyS): a therapeutic trichotomy for the treatment of B lymphocyte diseases.

Nardelli B, Moore PA, Li Y, Hilbert DM.

Leuk Lymphoma. 2002 Jul;43(7):1367-73. Review.

PMID:
12389615
6.

BLyS and B cell homeostasis.

Woodland RT, Schmidt MR, Thompson CB.

Semin Immunol. 2006 Oct;18(5):318-26. Epub 2006 Aug 22. Review.

PMID:
16931037
7.

BLyS: the pivotal determinant of peripheral B cell selection and lifespan.

Harless Smith S, Cancro MP.

Curr Pharm Des. 2003;9(23):1833-47. Review.

PMID:
12871188
8.

Homeostatic niche specification among naïve and activated B cells: a growing role for the BLyS family of receptors and ligands.

Crowley JE, Treml LS, Stadanlick JE, Carpenter E, Cancro MP.

Semin Immunol. 2005 Jun;17(3):193-9. Review.

PMID:
15826824
9.

111In-Labeled recombinant gelonin toxin-B lymphocyte stimulator protein fusion protein.

Chopra A.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2011 Feb 22 [updated 2011 Mar 31].

Supplemental Content

Support Center